CN103461322B - 用于冻存复苏后的细胞的保存液 - Google Patents
用于冻存复苏后的细胞的保存液 Download PDFInfo
- Publication number
- CN103461322B CN103461322B CN201210187672.9A CN201210187672A CN103461322B CN 103461322 B CN103461322 B CN 103461322B CN 201210187672 A CN201210187672 A CN 201210187672A CN 103461322 B CN103461322 B CN 103461322B
- Authority
- CN
- China
- Prior art keywords
- cell
- umbilical cord
- stem cells
- preservation liquid
- preservation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004321 preservation Methods 0.000 title claims abstract description 40
- 239000007788 liquid Substances 0.000 title claims abstract description 39
- 238000005138 cryopreservation Methods 0.000 title claims abstract description 18
- 210000000130 stem cell Anatomy 0.000 claims abstract description 58
- 210000004027 cell Anatomy 0.000 claims abstract description 47
- 210000003954 umbilical cord Anatomy 0.000 claims abstract description 45
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 239000001103 potassium chloride Substances 0.000 claims abstract description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 15
- 230000004899 motility Effects 0.000 claims description 4
- 230000003833 cell viability Effects 0.000 abstract description 6
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 230000003321 amplification Effects 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000001778 pluripotent stem cell Anatomy 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011278 co-treatment Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210187672.9A CN103461322B (zh) | 2012-06-07 | 2012-06-07 | 用于冻存复苏后的细胞的保存液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210187672.9A CN103461322B (zh) | 2012-06-07 | 2012-06-07 | 用于冻存复苏后的细胞的保存液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103461322A CN103461322A (zh) | 2013-12-25 |
CN103461322B true CN103461322B (zh) | 2016-08-03 |
Family
ID=49786565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210187672.9A Active CN103461322B (zh) | 2012-06-07 | 2012-06-07 | 用于冻存复苏后的细胞的保存液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103461322B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108925548A (zh) * | 2017-05-24 | 2018-12-04 | 西比曼生物科技(香港)有限公司 | 一种冻存细胞制剂及细胞复苏方式 |
CN109845725A (zh) * | 2019-01-25 | 2019-06-07 | 北京益华生物科技有限公司 | 细胞运输保存液及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277557B1 (en) * | 1997-10-21 | 2001-08-21 | Regents Of The University Of Minnesota | Infusible grade short-term cell storage medium |
CN1748499A (zh) * | 2005-10-11 | 2006-03-22 | 郭雷 | 肺保存液 |
WO2006057876A2 (en) * | 2004-11-22 | 2006-06-01 | Cedars-Sinai Medical Center | Methods and solutions for tissue preservation |
CN1784142A (zh) * | 2003-05-09 | 2006-06-07 | 生命血液医学公司 | 用于维持器官和细胞生存能力的组合物 |
CN101868536A (zh) * | 2007-10-04 | 2010-10-20 | 美鼎珐尔产品制药实验室股份公司 | 从人脐带分离和保存前体细胞的优化且确定的方法 |
CN102008507A (zh) * | 2010-11-21 | 2011-04-13 | 天津和泽干细胞科技有限公司 | 人脐带间充质干细胞抗肝纤维化注射液及其制备方法 |
-
2012
- 2012-06-07 CN CN201210187672.9A patent/CN103461322B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277557B1 (en) * | 1997-10-21 | 2001-08-21 | Regents Of The University Of Minnesota | Infusible grade short-term cell storage medium |
CN1784142A (zh) * | 2003-05-09 | 2006-06-07 | 生命血液医学公司 | 用于维持器官和细胞生存能力的组合物 |
WO2006057876A2 (en) * | 2004-11-22 | 2006-06-01 | Cedars-Sinai Medical Center | Methods and solutions for tissue preservation |
CN1748499A (zh) * | 2005-10-11 | 2006-03-22 | 郭雷 | 肺保存液 |
CN101868536A (zh) * | 2007-10-04 | 2010-10-20 | 美鼎珐尔产品制药实验室股份公司 | 从人脐带分离和保存前体细胞的优化且确定的方法 |
CN102008507A (zh) * | 2010-11-21 | 2011-04-13 | 天津和泽干细胞科技有限公司 | 人脐带间充质干细胞抗肝纤维化注射液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation;Rakhi Pal等;《JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE》;20080821;436–444 * |
Also Published As
Publication number | Publication date |
---|---|
CN103461322A (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dai et al. | Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects | |
Mizuno et al. | Using changes in hydrostatic and osmotic pressure to manipulate metabolic function in chondrocytes | |
CN102660497A (zh) | 脐带组织冻存、复苏以及分离和扩增干细胞的方法 | |
CN102511471A (zh) | 一种间充质干细胞冻存液及其制备方法 | |
ES2807897T3 (es) | Terapia con células madre basada en células madre procedentes de tejido adiposo | |
CN106237313A (zh) | 一种脐带间充质干细胞注射液及其制备方法和应用 | |
WO2007085210A3 (en) | Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method | |
CN101037666A (zh) | 一种动物细胞的低温保存溶液及保存方法 | |
JP2018531269A6 (ja) | 脂肪由来幹細胞に基づく幹細胞治療 | |
CN105211052B (zh) | 一种培养后的nkt细胞的冻存液及其制备方法 | |
CN107912424A (zh) | 一种犬间充质干细胞专用常温保存液及应用 | |
CN103461322B (zh) | 用于冻存复苏后的细胞的保存液 | |
RU2007148109A (ru) | Способ лечения хронической и острой почечной недостаточности с помощью фетальных стволовых и прогениторных клеток человека | |
CN106701682A (zh) | 由脐血分离造血干细胞并扩增cd34阳性细胞的方法 | |
Chaikhalyan et al. | Effects of acoustic and EHF impulses on multipotent stromal cells during formation of bone marrow containing heterotopic organs in tissue engineered constructions | |
CN102138553A (zh) | 一种临床用干细胞保存液 | |
CN107854730A (zh) | 交联cga的海藻酸钠‑明胶共混膜关节补片的制备方法及其应用 | |
CN104938479B (zh) | 组合物及其用途、脐带保存制剂及其制备方法 | |
RU2303631C1 (ru) | Среда для криоконсервирования мезенхимальных стволовых клеток и биотрансплантат с ее использованием | |
Herrmann et al. | A feasibility study of a multimodal stimulation bioreactor for the conditioning of stem cell seeded cardiac patches via electrical impulses and pulsatile perfusion | |
Farooque et al. | Protocol development for vitrification of tissue-engineered cartilage | |
Hussain et al. | Is a Bioengineered Heart From Recipient Tissues the Answer to the Shortage of Donors in Heart Transplantation? | |
Reis | Understanding cellular behaviour in early and late stage of MSD | |
CN104818246B (zh) | 一种兔脂肪干细胞的分离培养方法 | |
CN106967683A (zh) | 培养多能造血干细胞的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Applicant after: CELLULAR BIOMEDICINE GROUP (SHANGHAI) Ltd. Applicant after: CELLULAR BIOMEDICINE GROUP (WUXI) Ltd. Address before: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Applicant before: Zhenjing Biotechnology (Shanghai) Co.,Ltd. Applicant before: CHINA BIOTECH (WUXI) Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: STEMCELL BIOLOGICAL TECHNOLOGIES (SHANGHAI) CO., LTD. TO: CBM BIOTECHNOLOGY (SHANGHAI) CO., LTD. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180516 Address after: 201210 building 3, Faraday Road, China (Shanghai) free trade pilot area, Pudong New Area, Shanghai, China (3) Co-patentee after: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. Patentee after: SHANGHAI CELLULAR BIOPHARMACEUTICAL Group Ltd. Address before: No. 5, building No. 1, No. 333, Guiping Road, Xuhui District, Shanghai Co-patentee before: CELLULAR BIOMEDICINE GROUP (WUXI) Ltd. Patentee before: CELLULAR BIOMEDICINE GROUP (SHANGHAI) Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230816 Address after: 214174 area a, area a and area B on the first floor of building 7, No. 1699, Huishan Avenue, Huishan Economic Development Zone, Wuxi, Jiangsu Patentee after: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. Address before: 201210 building 3, Faraday Road, China (Shanghai) free trade pilot area, Pudong New Area, Shanghai, China (3) Patentee before: SHANGHAI CELLULAR BIOPHARMACEUTICAL Group Ltd. Patentee before: WUXI CELLULAR BIOPHARMACEUTICAL Group Ltd. |